{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:59:21Z","timestamp":1790819961710,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jtha.2025.07.015","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T05:26:52Z","timestamp":1758950812000},"page":"3075-3078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A central role of factor XI in a baboon model of Staphylococcus aureus sepsis"],"prefix":"10.1016","volume":"23","author":[{"given":"Nigel","family":"Mackman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana T.A.","family":"Sachetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.07.015_bib1","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1016\/j.jtha.2025.06.018","article-title":"Protective effects of FXI inhibition by abelacimab in a baboon model of live Staphylococcus aureus sepsis","volume":"23","author":"Silasi","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.07.015_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2025.07.015_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.07.015_bib4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/CCM.0b013e31827c09f8","article-title":"Benchmarking the incidence and mortality of severe sepsis in the United States","volume":"41","author":"Gaieski","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2025.07.015_bib5","first-page":"561","article-title":"Pathophysiologic responses of the subhuman primate in experimental septic shock","volume":"32","author":"Coalson","year":"1975","journal-title":"Lab Invest"},{"key":"10.1016\/j.jtha.2025.07.015_bib6","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00005373-199210000-00013","article-title":"Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody","volume":"33","author":"Hinshaw","year":"1992","journal-title":"J Trauma"},{"key":"10.1016\/j.jtha.2025.07.015_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/jth.14642","article-title":"Fondaparinux pentasaccharide reduces sepsis coagulopathy and promotes survival in the baboon model of Escherichia coli sepsis","volume":"18","author":"Keshari","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.07.015_bib8","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1172\/JCI112902","article-title":"Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon","volume":"79","author":"Taylor","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2025.07.015_bib9","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1172\/JCI116529","article-title":"Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock","volume":"91","author":"Creasey","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2025.07.015_bib10","first-page":"227","article-title":"Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons","volume":"26","author":"Taylor","year":"1988","journal-title":"Circulatory Shock"},{"key":"10.1016\/j.jtha.2025.07.015_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.07.015_bib12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.290.2.238","article-title":"Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial","volume":"290","author":"Abraham","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2025.07.015_bib13","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2025.07.015_bib14","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: The SCARLET Randomized Clinical Trial","volume":"321","author":"Vincent","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2025.07.015_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.molmed.2014.01.007","article-title":"Why have clinical trials in sepsis failed?","volume":"20","author":"Marshall","year":"2014","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jtha.2025.07.015_bib16","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41564-022-01237-2","article-title":"Integrated host-microbe plasma metagenomics for sepsis diagnosis in a prospective cohort of critically ill adults","volume":"7","author":"Kalantar","year":"2022","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jtha.2025.07.015_bib17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S2213-2600(23)00237-0","article-title":"Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials","volume":"11","author":"Sinha","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jtha.2025.07.015_bib19","first-page":"127","article-title":"Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody","volume":"33","author":"Taylor","year":"1991","journal-title":"Circulatory Shock"},{"key":"10.1016\/j.jtha.2025.07.015_bib20","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1055\/a-2091-7006","article-title":"Monocyte tissue factor expression: lipopolysaccharide induction and roles in pathological activation of coagulation","volume":"123","author":"Sachetto","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.07.015_bib21","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood.V87.6.2337.bloodjournal8762337","article-title":"Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase","volume":"87","author":"Jansen","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.07.015_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1172\/JCI116201","article-title":"The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons","volume":"91","author":"Pixley","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2025.07.015_bib23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4049\/jimmunol.160.1.475","article-title":"Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock","volume":"160","author":"Jansen","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jtha.2025.07.015_bib24","first-page":"179","article-title":"Nickel sequestering by polyphosphate bodies in Staphylococcus aureus","volume":"93","author":"Gonzalez","year":"1998","journal-title":"Microbios"},{"key":"10.1016\/j.jtha.2025.07.015_bib25","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1182\/blood-2010-01-266791","article-title":"Polyphosphate exerts differential effects on blood clotting, depending on polymer size","volume":"116","author":"Smith","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.07.015_bib26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood.2020009345","article-title":"Factor XII plays a pathogenic role in organ failure and death in baboons challenged with Staphylococcus aureus","volume":"138","author":"Silasi","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.07.015_bib27","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1182\/bloodadvances.2018029983","article-title":"Inhibition of contact-mediated activation of factor XI protects baboons against S aureus\u2013induced organ damage and death","volume":"3","author":"Silasi","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.07.015_bib28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJMoa2105872","article-title":"Abelacimab for prevention of venous thromboembolism","volume":"385","author":"Verhamme","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.07.015_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1056\/NEJMoa2406674","article-title":"Abelacimab versus rivaroxaban in patients with atrial fibrillation","volume":"392","author":"Ruff","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.07.015_bib30","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.4049\/jimmunol.2000398","article-title":"Cross-talk between the complement pathway and the contact activation system of coagulation: activated factor XI neutralizes complement factor H","volume":"206","author":"Puy","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.jtha.2025.07.015_bib31","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1182\/blood.2023022257","article-title":"Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivo","volume":"144","author":"Puy","year":"2024","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625004659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625004659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:23:53Z","timestamp":1790817833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625004659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1538783625004659"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.07.015","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A central role of factor XI in a baboon model of Staphylococcus aureus sepsis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.06.018","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}